|
Clinical Studies
Citations 61-70 of 1662 total displayed.
|
Past content
(since Oct 2000):
|
- Original Articles
Effects of Chronic Baroreceptor Stimulation on the Autonomic Cardiovascular Regulation in Patients With Drug-Resistant Arterial Hypertension
- Kerstin Wustmann, Jan P. Kucera, Ingrid Scheffers, Markus Mohaupt, Abraham A. Kroon, Peter W. de Leeuw, Jürg Schmidli, Yves Allemann, and Etienne Delacrétaz
Hypertension 2009;54:530-536; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134023
[Abstract]
[Full text]
- Original Articles
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk: Effects of Acetyl-L-Carnitine Therapy
- Piero Ruggenenti, Dario Cattaneo, Giacomina Loriga, Franca Ledda, Nicola Motterlini, Giulia Gherardi, Silvia Orisio, and Giuseppe Remuzzi
Hypertension 2009;54:567-574; published online before print as doi:10.1161/HYPERTENSIONAHA.109.132522
[Abstract]
[Full text]
- Original Articles
Nocturia, Nocturnal Activity, and Nondipping
- Rajiv Agarwal, Robert P. Light, Jennifer E. Bills, and Lindsey A. Hummel
Hypertension 2009;54:646-651; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135822
[Abstract]
[Full text]
- Editorial Commentaries
Wave Intensity Analysis and Central Blood Pressure
- James D. Cameron
Hypertension published August 31, 2009, doi:10.1161/HYPERTENSIONAHA.109.137638
[Abstract]
- Brief Reviews
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension. Achievements and Perspectives
- Guido Grassi
Hypertension published August 31, 2009, doi:10.1161/HYPERTENSIONAHA.108.119883
[Abstract]
- Scientific Contributions
Differences in the Magnitude of Wave Reflection Account for Differential Effects of Amlodipine- Versus Atenolol-Based Regimens on Central Blood Pressure. An Anglo-Scandinavian Cardiac Outcome Trial Substudy
- Charlotte H. Manisty, Andrew Zambanini, Kim H. Parker, Justin E. Davies, Darrel P. Francis, Jamil Mayet, Simon A. McG Thom, Alun D. Hughes on behalf of the Anglo-Scandinavian Cardiac Outcome Trial Investigators
Hypertension published August 24, 2009, doi:10.1161/HYPERTENSIONAHA.108.125740
[Abstract]
- Editorial Commentaries
Losartan Metabolite EXP3179. An AT1-Receptor–Independent Treatment Strategy for Patients With the Metabolic Syndrome?
- Gian Paolo Rossi
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.138883
[Abstract]
- Scientific Contributions
Contribution of Endothelin 1 to the Vascular Effects of Diesel Exhaust Inhalation in Humans
- Jeremy P. Langrish, Magnus Lundbäck, Nicholas L. Mills, Neil R. Johnston, David J. Webb, Thomas Sandström, Anders Blomberg, and David E. Newby
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.135947
[Abstract]
- Scientific Contributions
Chronic Treatment With Losartan Results in Sufficient Serum Levels of the Metabolite EXP3179 for PPAR Activation
- Kai Kappert, Oleg Tsuprykov, Jan Kaufmann, Jan Fritzsche, Ingo Ott, Matthias Goebel, Ilse Nirmala Bähr, Paul-Laszlo Häßle, Ronald Gust, Eckart Fleck, Thomas Unger, Philipp Stawowy, and Ulrich Kintscher
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.132886
[Abstract]
- Editorial Commentaries
Central Blood Pressure Under Angiotensin and Calcium Channel Blockade
- Michel E. Safar, Athanase Protogerou, and Jacques Blacher
Hypertension published August 10, 2009, doi:10.1161/HYPERTENSIONAHA.109.137406
[Abstract]
|
|
